Stocks / NASDAQ / Aadi Bioscience Inc.

Aadi Bioscience Inc.

Our Opinion

Aadi Bioscience Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Based on animal studies and the mechanism of action, FYARRO can cause fetal harm when administered to a pregnant woman.” Read the following article

Company Description

Aadi Bioscience, Inc, formerly Aerpio Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing precision therapies for genetically defined cancers. It develops therapies for cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes.

Company Website: